Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Ten Cate

Showing results (91-100 of 189) with videos related to

Pageof 19
Sort By:
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|June 10, 2020
Organisation of care for patients using direct oral anticoagulantsA J W Gulpen, J K van Dijk, N L Damen, et al.
Thrombosis Research|October 8, 2014
Increased factor XIa levels in patients with a first acute myocardial infarction: the introduction of a new thrombin generation based factor XIa assayR Loeffen, R van Oerle, P G de Groot, et al.
Thrombosis Research|March 4, 2020
Predictive value of D-dimer testing for the diagnosis of venous thrombosis in unusual locations: A systematic reviewL Ordieres-Ortega, P Demelo-Rodríguez, F Galeano-Valle, et al.
American Journal of Respiratory and Critical Care Medicine|July 9, 1998
Differential effects of anti-cytokine treatment on bronchoalveolar hemostasis in endotoxemic chimpanzeesM Levi, T van Der POLL, H ten CATE, et al.
Thrombosis Research|July 15, 1985
Anticoagulant effects of a low molecular weight heparinoid (Org 10172) in human volunteers and haemodialysis patientsH ten Cate, C P Henny, J W ten Cate, et al.
Blood|March 15, 1995
Inactivation of factor XIa in human plasma assessed by measuring factor XIa-protease inhibitor complexes: major role for C1-inhibitorW A Wuillemin, M Minnema, J C Meijers, et al.
The Journal of Clinical Investigation|September 1, 1993
The activation of factor X and prothrombin by recombinant factor VIIa in vivo is mediated by tissue factorH ten Cate, K A Bauer, M Levi, et al.
The Journal of Cardiovascular Surgery|January 1, 1989
Veno-venous bypass without systemic heparinization using a centrifugal pump: a blind comparison of a heparin bonded circuit versus a non heparin bonded circuitV P van der Hulst, C P Henny, A C Moulijn, et al.
Thrombosis Research|July 1, 1991
Partial in vivo neutralisation of plasma anticoagulant effects of Lomoparan (Org 10172) by protamine chlorideJ C Stiekema, H P Wijnand, H ten Cate, et al.
Journal of Thrombosis and Haemostasis : JTH|July 2, 2009
Biological variation in inflammatory and hemostatic markersG Rudez, P Meijer, H M H Spronk, et al.
Pageof 19

Showing results (91-100 of 189) with videos related to

Sort By:
Pageof 19
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|June 10, 2020
Organisation of care for patients using direct oral anticoagulantsA J W Gulpen, J K van Dijk, N L Damen, et al.
Thrombosis Research|October 8, 2014
Increased factor XIa levels in patients with a first acute myocardial infarction: the introduction of a new thrombin generation based factor XIa assayR Loeffen, R van Oerle, P G de Groot, et al.
Thrombosis Research|March 4, 2020
Predictive value of D-dimer testing for the diagnosis of venous thrombosis in unusual locations: A systematic reviewL Ordieres-Ortega, P Demelo-Rodríguez, F Galeano-Valle, et al.
American Journal of Respiratory and Critical Care Medicine|July 9, 1998
Differential effects of anti-cytokine treatment on bronchoalveolar hemostasis in endotoxemic chimpanzeesM Levi, T van Der POLL, H ten CATE, et al.
Thrombosis Research|July 15, 1985
Anticoagulant effects of a low molecular weight heparinoid (Org 10172) in human volunteers and haemodialysis patientsH ten Cate, C P Henny, J W ten Cate, et al.
Blood|March 15, 1995
Inactivation of factor XIa in human plasma assessed by measuring factor XIa-protease inhibitor complexes: major role for C1-inhibitorW A Wuillemin, M Minnema, J C Meijers, et al.
The Journal of Clinical Investigation|September 1, 1993
The activation of factor X and prothrombin by recombinant factor VIIa in vivo is mediated by tissue factorH ten Cate, K A Bauer, M Levi, et al.
The Journal of Cardiovascular Surgery|January 1, 1989
Veno-venous bypass without systemic heparinization using a centrifugal pump: a blind comparison of a heparin bonded circuit versus a non heparin bonded circuitV P van der Hulst, C P Henny, A C Moulijn, et al.
Thrombosis Research|July 1, 1991
Partial in vivo neutralisation of plasma anticoagulant effects of Lomoparan (Org 10172) by protamine chlorideJ C Stiekema, H P Wijnand, H ten Cate, et al.
Journal of Thrombosis and Haemostasis : JTH|July 2, 2009
Biological variation in inflammatory and hemostatic markersG Rudez, P Meijer, H M H Spronk, et al.
Pageof 19